Wed, 16 May 2018
With a population of 741 million people, Europe’s a huge market for medicine, yet most U.S. investors avoid European drugmakers, including Sanofi. On today's episode, we explain how drugs win approval in Europe and why Sanofi ought to be on your radar.
Thanks to Molekule for supporting our channel. Get $75 off your first order at http://www.molekule.com code fool.